Bottom line
How much do SWHFX and JEHSX overlap?
73% of their top holdings overlap by weight. 14 securities appear in both funds' top 25, making up 55.3% of SWHFX's assets and 55.2% of JEHSX's. They are largely the same portfolio — owning both adds little diversification.
JEHSX holds far more positions (173 vs 80), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings SWHFX and JEHSX have in common
| Holding | % of SWHFX | % of JEHSX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 13.92% | 14.30% | 13.92% |
| Johnson & Johnson | 6.94% | 6.33% | 6.33% |
| AbbVie Inc | 5.81% | 5.28% | 5.28% |
| Merck & Co Inc | 4.98% | 4.21% | 4.21% |
| UnitedHealth Group Inc | 4.74% | 5.95% | 4.74% |
| Gilead Sciences Inc | 3.24% | 2.95% | 2.95% |
| Amgen Inc | 2.58% | 1.90% | 1.90% |
| Bristol-Myers Squibb Co | 2.44% | 2.22% | 2.22% |
| Thermo Fisher Scientific Inc | 2.16% | 2.67% | 2.16% |
| Stryker Corp | 2.11% | 1.87% | 1.87% |
| Vertex Pharmaceuticals Inc | 1.89% | 2.38% | 1.89% |
| Abbott Laboratories | 1.60% | 2.00% | 1.60% |
| Danaher Corp | 1.47% | 1.51% | 1.47% |
| Elevance Health Inc | 1.45% | 1.63% | 1.45% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in SWHFX
- Novartis AG — 2.92%
- Medtronic PLC — 2.29%
- Roche Holding AG — 2.29%
- Gsk Plc — 1.73%
- Boston Scientific Corp — 1.60%
- Cigna Group/The — 1.51%
- Incyte Corp — 1.37%
- Ipsen SA — 1.34%
- Sanofi SA — 1.31%
- Becton Dickinson & Co — 1.24%
- Astellas Pharma Inc — 1.19%
Only in JEHSX
- Intuitive Surgical Inc. — 1.98%
- Natera Inc. — 1.49%
- Guardant Health Inc. — 1.28%
- Cardinal Health Inc. — 1.09%
- Royalty Pharma plc — 1.02%
- Tenet Healthcare Corporation — 0.99%
- CVS Health Corporation — 0.98%
- Kymera Therapeutics Inc. — 0.93%
- Protagonist Therapeutics Inc. — 0.90%
- BrightSpring Health Services Inc. — 0.88%
- Moderna Inc. — 0.87%
Asset mix
| Asset type | SWHFX | JEHSX |
|---|---|---|
| Stocks | 99.0% | 99.0% |
| Cash & short-term funds | — | 0.9% |
| Bonds | — | 0.1% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Country mix
| Country | SWHFX | JEHSX |
|---|---|---|
| US | 78.6% | 95.0% |
| CH | 5.2% | 0.3% |
| IE | 4.5% | 0.9% |
| GB | 3.4% | 0.8% |
| FR | 2.6% | 0.3% |
| JP | 2.3% | 0.5% |
| NL | 0.7% | 1.0% |
| DK | 0.7% | 0.7% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do SWHFX and JEHSX overlap?
What stocks do SWHFX and JEHSX have in common?
Should I own both SWHFX and JEHSX?
Which holds more stocks, SWHFX or JEHSX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.